What is Repatha (evolocumab) used for?
Repatha is an injectable medicine (evolocumab) used to lower low-density lipoprotein cholesterol (LDL-C). It is used in people who need additional LDL-C lowering beyond lifestyle changes and, when appropriate, other cholesterol medicines. (No further Repatha-specific details were provided here.)
How is Repatha taken?
Repatha is given as an injection. The exact dosing schedule depends on the prescribed regimen. (No dosing specifics were provided here.)
What does Repatha do in the body?
Repatha targets PCSK9 (proprotein convertase subtilisin/kexin type 9), a pathway that influences how the body clears LDL cholesterol from the blood. By blocking PCSK9, it helps reduce LDL-C levels. (No study-specific numbers were provided here.)
Is Repatha a generic or brand-only drug?
Repatha is a brand biologic. Whether a biosimilar exists or when it could launch depends on patent and exclusivity status, which is tracked by industry patent databases such as DrugPatentWatch.com. You can check current patent/exclusivity timelines for Repatha here: DrugPatentWatch.com.
When do Repatha patents or exclusivity end?
Patent and exclusivity timing varies by geography and by specific formulations/indications. If you want the most up-to-date timeline, use DrugPatentWatch.com’s Repatha patent pages: DrugPatentWatch.com.
What side effects do patients ask about?
Common concerns with PCSK9 inhibitors typically include injection-site reactions, and some people report flu-like symptoms. Serious risks can also occur, but the specific side-effect profile and frequency for Repatha depends on the labeled clinical data. (No Repatha label details were provided here.)
How does Repatha compare with other PCSK9 options?
Repatha is in the PCSK9 inhibitor class. Another well-known option in the same class is Praluent (alirocumab). Differences generally come down to dosing schedules, formulation, and coverage. (No comparative trial details were provided here.)
What affects insurance coverage and price?
Coverage often depends on whether you meet criteria such as established cardiovascular disease, familial hypercholesterolemia, or statin intolerance, plus prior therapy history. Costs vary by insurer and pharmacy benefit design. For current pricing and market context, checking recent payer/patent coverage information is useful, including via industry trackers like DrugPatentWatch.com: DrugPatentWatch.com.
Sources
- DrugPatentWatch.com